Risk‐Adapted Management and Outcomes of Tailgut Cysts: A 25‐Year Single‐Center Retrospective Experience
International Journal of Cancer · 18.11.2026
DOI: 10.1002/ijc.70818 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 18.11.2026. Verfasst von Francesca Roufael und 17 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Tailgut cysts are rare congenital retrorectal lesions. Because the risk of malignancy remains uncertain, resection has historically been recommended even for asymptomatic patients. We examined whether clinical and imaging features can identify patients suitable for active surveillance. Patients diagnosed with a tailgut cyst at a tertiary cancer center between 1996 and 2021 were identified from radiology and pathology databases. Demographic, clinical, imaging, operative, pathologic, and oncologic data were reviewed. Management was individualized after multidisciplinary review. Survival was estimated using the Kaplan–Meier method. Fifty‐four patients were included; 47 (87%) had benign disease and 7 (13%) had malignant disease. Malignancy was present at diagnosis in all cases and occurred exclusively in symptomatic patients. Malignancy was associated with older age (median 57 vs. 45 years, p = 0.036) and rectal pain at presentation (86% vs. 30%, p = 0.008). On imaging, malignant cysts were significantly larger and more likely to demonstrate solid components, calcifications, and adjacent structure involvement. Twenty patients with benign‐appearing cysts were enrolled in active surveillance. In this cohort, no malignant events were observed during follow‐up, with a 5‐year cancer‐free survival of 100%. Five‐year overall survival was 28.6% for malignant versus 91.9% for benign cysts ( p < 0.0001). Malignant tailgut cysts appear to represent a clinically and radiographically distinct subset present at diagnosis. Asymptomatic patients with benign‐appearing cysts demonstrated excellent long‐term outcomes under active surveillance. These findings suggest that a risk‐adapted management strategy incorporating symptoms and imaging features may help guide selection between surgery and surveillance.
Zitieren
APA
Roufael, F., Bauer, P. S., Bahceci, D., Karagkounis, G., Wei, I. H., Abbass, M. A., Widmar, M., Smith, J. J., Nash, G. M., Weiser, M. R., Paty, P. B., Yildirim, O., Paroder, V., Cercek, A., Saltz, L. B., Shia, J., Garcia‐Aguilar, J., & Pappou, E. (2026). Risk‐Adapted Management and Outcomes of Tailgut Cysts: A 25‐Year Single‐Center Retrospective Experience. International Journal of Cancer. https://doi.org/10.1002/ijc.70818
Vancouver
Roufael F, Bauer PS, Bahceci D, Karagkounis G, Wei IH, Abbass MA, et al. Risk‐Adapted Management and Outcomes of Tailgut Cysts: A 25‐Year Single‐Center Retrospective Experience. International Journal of Cancer. 2026. doi:10.1002/ijc.70818
BibTeX
@article{Roufael2026,
author = {Roufael, Francesca and Bauer, Philip S. and Bahceci, Dorukhan and Karagkounis, Georgios and Wei, Iris H. and Abbass, Mohammad Ali and Widmar, Maria and Smith, J. Joshua and Nash, Garrett M. and Weiser, Martin R. and Paty, Philip B. and Yildirim, Onur and Paroder, Viktoriya and Cercek, Andrea and Saltz, Leonard B. and Shia, Jinru and Garcia‐Aguilar, Julio and Pappou, Emmanouil},
title = {Risk‐Adapted Management and Outcomes of Tailgut Cysts: A 25‐Year Single‐Center Retrospective Experience},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70818}
}
EUVIMED